Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7559)
All Articles published online
|
Publishing Process of This Article
|
Jun 14, 2014 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Saridaki Z, Souglakos J, Georgoulias V. Prognostic and predictive significance of MSI in stages II/III colon cancer. World J Gastroenterol 2014; 20(22): 6809-6814 [PMID: 24944470 DOI: 10.3748/wjg.v20.i22.6809] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i22/6809.htm |
| Number | Citing Articles |
| 1 |
Yann Touchefeu, Marie Provost-Dewitte, Thierry Lecomte, Alain Morel, Isabelle Valo, Jean-François Mosnier, Céline Bossard, Juliette Eugène, Emilie Duchalais, Jérôme Chetritt, Serge Guyetant, Stéphane Bézieau, Hélène Senellart, Morgane Caulet, Estelle Cauchin, Tamara Matysiak-Budnik. Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer. European Journal of Gastroenterology & Hepatology 2016; 28(12): 1394 doi: 10.1097/MEG.0000000000000725
|
| 2 |
Stanley Kim. Colon Cancer: What's New?. Medical Journal of Southern California Clinicians 2021; : 12 doi: 10.38206/140103
|
| 3 |
Pauline Gilson, Jean-Louis Merlin, Alexandre Harlé. Detection of Microsatellite Instability: State of the Art and Future Applications in Circulating Tumour DNA (ctDNA). Cancers 2021; 13(7): 1491 doi: 10.3390/cancers13071491
|
| 4 |
Watcharin Loilome, Sasithorn Kadsanit, Kanha Muisook, Puangrat Yongvanit, Nisana Namwat, Anchalee Techasen, Anucha Puapairoj, Narong Khuntikeo, Pichai Phonjit. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma. Oncology Letters 2017; 13(2): 639 doi: 10.3892/ol.2016.5477
|
| 5 |
Dana M. Roque, Alessandro D. Santin. Uterine cancer, mutational phenotype, and the era of immune checkpoint blockade. Expert Review of Clinical Immunology 2017; 13(3): 175 doi: 10.1080/1744666X.2017.1266938
|
| 6 |
Okihide Suzuki, Keisuke Kumamoto, Minoru Fukuchi, Noriyasu Chika, Satoshi Hatano, Takeaki Matsuzawa, Yoichi Kumagai, Keiichiro Ishibashi, Erito Mochiki, Hideyuki Ishida. Lynch Syndrome Caused by a Germ Line Mutation in <i>MSH6</i>. The Japanese Journal of Gastroenterological Surgery 2015; 48(7): 618 doi: 10.5833/jjgs.2014.0181
|
| 7 |
Chi-Jung Huang, Shih-Hung Huang, Chih-Cheng Chien, Henry Hsin-Chung Lee, Shung-Haur Yang, Chun-Chao Chang, Chia-Long Lee. Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation. Oncology Letters 2016; 12(6): 4427 doi: 10.3892/ol.2016.5275
|
| 8 |
Jesper Bertram Bramsen, Mads Heilskov Rasmussen, Halit Ongen, Trine Block Mattesen, Mai-Britt Worm Ørntoft, Sigrid Salling Árnadóttir, Juan Sandoval, Teresa Laguna, Søren Vang, Bodil Øster, Philippe Lamy, Mogens Rørbæk Madsen, Søren Laurberg, Manel Esteller, Emmanouil Theophilos Dermitzakis, Torben Falck Ørntoft, Claus Lindbjerg Andersen. Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer. Cell Reports 2017; 19(6): 1268 doi: 10.1016/j.celrep.2017.04.045
|
| 9 |
Mitsuro Kanda, Koji Oba, Toru Aoyama, Kosuke Kashiwabara, Shuhei Mayanagi, Hiromichi Maeda, Michitaka Honda, Chikuma Hamada, Sotaro Sadahiro, Junichi Sakamoto, Shigetoyo Saji, Takaki Yoshikawa. Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials. Diseases of the Colon & Rectum 2018; 61(4): 461 doi: 10.1097/DCR.0000000000001022
|
| 10 |
Seçil AK AKSOY, Berrin TUNCA, Tuncay YILMAZLAR, Ersin ÖZTÜRK, Fuat AKSOY, Özgen IŞIK, Ömer YERCİ, Nesrin UĞRAŞ, Özkan KANAT, Melis MUTLU, Çağla TEKİN. MikroRNA-106a’nın Yüksek Ekspresyonu Kolorektal Kanserlerde Mikrosatellit İnstablite Durumu ile İlişkilidir. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2021; 47(2): 225 doi: 10.32708/uutfd.917784
|
| 11 |
Robin M. J. M. van Geel, Jos H. Beijnen, René Bernards, Jan H.M. Schellens. Treatment Individualization in Colorectal Cancer. Current Colorectal Cancer Reports 2015; 11(6): 335 doi: 10.1007/s11888-015-0288-z
|
| 12 |
Anant Ramaswamy, Rushabh Kothari, Ashwin Desouza, Tarachand Gupta, Sandeep Bairwa, Akhil Kapoor, Amit Kumar, Pradeep Ventrapati, Mukta Ramadwar, Sarika Mandavkar, Amit Kumar, Nita Chavan, Avanish Saklani, Vikas Ostwal. Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX. South Asian Journal of Cancer 2019; 8(03): 160 doi: 10.4103/sajc.sajc_176_18
|
| 13 |
Włodzimierz Otto, Finlay Macrae, Janusz Sierdziński, Justyna Smaga, Maria Król, Ewa Wilińska, Krzysztof Zieniewicz. Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma. Medicine 2019; 98(1): e13956 doi: 10.1097/MD.0000000000013956
|
| 14 |
Hung-Hsin Lin, Nien-Chih Wei, Teh-Ying Chou, Chun-Chi Lin, Yuan-Tsu Lan, Shin-Ching Chang, Huann-Sheng Wang, Shung-Haur Yang, Wei-Shone Chen, Tzu-Chen Lin, Jen-Kou Lin, Jeng-Kai Jiang. Building personalized treatment plans for early-stage colorectal cancer patients. Oncotarget 2017; 8(8): 13805 doi: 10.18632/oncotarget.14638
|
| 15 |
Paul J. Lee, Samantha McNulty, Eric J. Duncavage, Jonathan W. Heusel, Ian S. Hagemann. Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair. International Journal of Gynecological Pathology 2018; 37(6): 581 doi: 10.1097/PGP.0000000000000459
|
| 16 |
Matthew Evans, Matthew Smith, Brendan O'Sullivan, Philippe Taniere. Molecular testing of gastrointestinal tumours. Diagnostic Histopathology 2017; 23(10): 442 doi: 10.1016/j.mpdhp.2017.08.004
|
| 17 |
Zuhuan Gan, Qiyuan Zou, Yan Lin, Zihai Xu, Zhong Huang, Zhichao Chen, Yufeng Lv. Identification of a 13‑gene‑based classifier as a potential biomarker to predict the effects of fluorouracil‑based chemotherapy in colorectal cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10159
|
| 18 |
Daniel W. Nelson, Clay Merritt, Shu-Ching Chang, Gary Grunkemeier, Scott R. Steele, Melanie Goldfarb. Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer. Journal of Gastrointestinal Surgery 2021; 25(1): 220 doi: 10.1007/s11605-020-04757-6
|
| 19 |
Stefania Morganti, Paolo Tarantino, Emanuela Ferraro, Paolo D’Amico, Bruno Achutti Duso, Giuseppe Curigliano. Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics. Advances in Experimental Medicine and Biology 2019; 1168: 9 doi: 10.1007/978-3-030-24100-1_2
|
| 20 |
Anna Giammanco, Rita Anzalone, Nicola Serra, Giuseppa Graceffa, Salvatore Vieni, Nunzia Scibetta, Teresa Rea, Giuseppina Capra, Teresa Fasciana. Helicobacter pylori and Epstein–Barr Virus Co-Infection in Gastric Disease: What Is the Correlation with p53 Mutation, Genes Methylation and Microsatellite Instability in a Cohort of Sicilian Population?. International Journal of Molecular Sciences 2023; 24(9): 8104 doi: 10.3390/ijms24098104
|
| 21 |
Bo Young Oh, Jung Wook Huh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun. Prognostic factors in sporadic colon cancer with high-level microsatellite instability. Surgery 2016; 159(5): 1372 doi: 10.1016/j.surg.2015.11.028
|
| 22 |
Winson Jianhong Tan, Julie Liana Hamzah, Sanchalika Acharyya, Fung Joon Foo, Kiat Hon Lim, Iain Bee Huat Tan, Choong Leong Tang, Min Hoe Chew. Evaluation of Long-Term Outcomes of Microsatellite Instability Status in an Asian Cohort of Sporadic Colorectal Cancers. Journal of Gastrointestinal Cancer 2018; 49(3): 311 doi: 10.1007/s12029-017-9953-6
|
| 23 |
Kevin Kniery, Madhuri Nishtala, Scott R. Steele. Staging, prognosis, and survivorship in colon cancer. Seminars in Colon and Rectal Surgery 2016; 27(4): 193 doi: 10.1053/j.scrs.2016.04.017
|
| 24 |
Ming Yin, Feng Hong, Qi-En Wang. Metastasis. 2022; : 117 doi: 10.36255/exon-publications.metastasis.dna-damage-response
|
| 25 |
RoopaR Paulose, DivyaA Ail, Shital Biradar, Anu Vasudevan, KR Sundaram. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India. Indian Journal of Cancer 2019; 56(4): 302 doi: 10.4103/ijc.IJC_365_18
|
| 26 |
Liren Li, Wenhao Zhou, Qian Li, Pansong Li, Ling Yang, Xuefeng Xia, Xin Yi, Desen Wan. Tumor-derived mutations in postoperative plasma of colorectal cancer with microsatellite instability. Translational Oncology 2021; 14(1): 100945 doi: 10.1016/j.tranon.2020.100945
|
| 27 |
Angelika Copija, Dariusz Waniczek, Andrzej Witkoś, Katarzyna Walkiewicz, Ewa Nowakowska-Zajdel. Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients. International Journal of Molecular Sciences 2017; 18(1): 107 doi: 10.3390/ijms18010107
|
| 28 |
Youn Young Park, Chang Hyeok An, Seong Taek Oh, Eun Deock Chang, Jaeim Lee. Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma. Medicine 2019; 98(32): e16709 doi: 10.1097/MD.0000000000016709
|
| 29 |
A. Grothey, M. Fakih, J. Tabernero. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines. Annals of Oncology 2021; 32(8): 959 doi: 10.1016/j.annonc.2021.03.206
|
| 30 |
Kazuaki Okamoto, Hiroaki Nozawa, Shigenobu Emoto, Koji Murono, Kazuhito Sasaki, Soichiro Ishihara. Adjuvant chemotherapy for elderly patients with colorectal cancer: a single-centre observational study in Japan. Journal of Chemotherapy 2023; : 1 doi: 10.1080/1120009X.2023.2273096
|
| 31 |
E. Ryan, K. Sheahan, B. Creavin, H.M. Mohan, D.C. Winter. The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing. Critical Reviews in Oncology/Hematology 2017; 116: 38 doi: 10.1016/j.critrevonc.2017.05.006
|
| 32 |
Raul S. Gonzalez, Kay Washington, Chanjuan Shi. Current applications of molecular pathology in colorectal carcinoma. Applied Cancer Research 2017; 37(1) doi: 10.1186/s41241-017-0020-1
|
| 33 |
Giovanni Germano, Nabil Amirouchene-Angelozzi, Giuseppe Rospo, Alberto Bardelli. The Clinical Impact of the Genomic Landscape of Mismatch Repair–Deficient Cancers. Cancer Discovery 2018; 8(12): 1518 doi: 10.1158/2159-8290.CD-18-0150
|
| 34 |
Matej Horvat, Uroš Potočnik, Katja Repnik, Rajko Kavalar, Borut Štabuc. Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/2139489
|
| 35 |
Josep Tabernero, Javier Ros, Elena Élez. The Evolving Treatment Landscape in BRAF-V600E–Mutated Metastatic Colorectal Cancer. American Society of Clinical Oncology Educational Book 2022; (42): 254 doi: 10.1200/EDBK_349561
|
| 36 |
Zhi-na Wang, Dan Liu, Bin Yin, Wen-yi Ju, Hui-zhong Qiu, Yi Xiao, Yuan-jia Chen, Xiao-zhong Peng, Chong-mei Lu. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin. Oncotarget 2017; 8(22): 36185 doi: 10.18632/oncotarget.15873
|
| 37 |
Sotaro Sadahiro, Kazuhiro Sakamoto, Takashi Tsuchiya, Takao Takahashi, Hiroki Ohge, Toshihiko Sato, Ken Kondo, Yutaka Ogata, Hideo Baba, Michio Itabashi, Masataka Ikeda, Madoka Hamada, Kiyoshi Maeda, Hiroyuki Masuko, Keiichi Takahashi, Junichi Sakamoto, Mitsuo Kusano, Ichinosuke Hyodo, Masataka Taguri, Satoshi Morita. Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201). BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09267-z
|
| 38 |
Maria Sfakianaki, Maria Tzardi, Konstantina Tsantaki, Chara Koutoulaki, Ippokratis Messaritakis, Galateia Datseri, Eleni Moustou, Dimitrios Mavroudis, John Souglakos. Evaluation of Microsatellite Instability Molecular Analysis versus Immuno-Histochemical Interpretation in Malignant Neoplasms with Different Localizations. Cancers 2023; 15(2): 353 doi: 10.3390/cancers15020353
|
| 39 |
Choukri Elm’hadi, Mohamed Tarchouli, Mohamed Reda Khmamouche, Rachid Tanz, Mohammed Elfahssi, Fouad Kettani, Abdelmounaim Ait Ali, Hassan Errihani, Mohammed Ichou. Intestinal intussusception in a young women: unusual cause and specific management. World Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0660-0
|
| 40 |
|
| 41 |
Masato Yozu, M. Priyanthi Kumarasinghe, Ian S. Brown, Anthony J. Gill, Christophe Rosty. Australasian Gastrointestinal Pathology Society (AGPS) consensus guidelines for universal defective mismatch repair testing in colorectal carcinoma. Pathology 2019; 51(3): 233 doi: 10.1016/j.pathol.2018.11.014
|
| 42 |
Sumana Narayanan, Emmanuel Gabriel, Kristopher Attwood, Patrick Boland, Steven Nurkin. Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Cancer. Clinical Colorectal Cancer 2018; 17(4): e671 doi: 10.1016/j.clcc.2018.07.001
|
| 43 |
John H. Strickler, Christina Wu, Tanios Bekaii-Saab. Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches. Cancer Treatment Reviews 2017; 60: 109 doi: 10.1016/j.ctrv.2017.08.006
|
| 44 |
Miranda D. Stobbe, Gian A. Thun, Andrea Diéguez-Docampo, Meritxell Oliva, Justin P. Whalley, Emanuele Raineri, Ivo G. Gut, Jian Ma. Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer. PLOS Computational Biology 2019; 15(11): e1007496 doi: 10.1371/journal.pcbi.1007496
|
| 45 |
Pauline Gilson, Julien Levy, Marie Rouyer, Jessica Demange, Marie Husson, Céline Bonnet, Julia Salleron, Agnès Leroux, Jean-Louis Merlin, Alexandre Harlé. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73421-5
|
| 46 |
Surein Arulananda, Bibhusal Thapa, Marzena Walkiewicz, Giada V. Zapparoli, David S. Williams, Alexander Dobrovic, Thomas John. Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology 2018; 13(10): 1588 doi: 10.1016/j.jtho.2018.07.015
|
| 47 |
Ji Ha Lim, Jung Wook Huh, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Yong Beom Cho, Yoon Ah Park, Jung Kyong Shin. Comparison of Long-Term Survival Outcomes of T4a and T4b Colorectal Cancer. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.780684
|
| 48 |
Vito Amodio, Simona Lamba, Rosaria Chilà, Chiara M. Cattaneo, Benedetta Mussolin, Giorgio Corti, Giuseppe Rospo, Enrico Berrino, Claudio Tripodo, Federica Pisati, Alice Bartolini, Maria Costanza Aquilano, Silvia Marsoni, Gianluca Mauri, Caterina Marchiò, Sergio Abrignani, Federica Di Nicolantonio, Giovanni Germano, Alberto Bardelli. Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance. Cancer Cell 2023; 41(1): 196 doi: 10.1016/j.ccell.2022.12.003
|
| 49 |
GayathriG Nair, Vijayalakshmi Nair, UshaMary Abraham. Association of clinicopathological features with DNA mismatch repair status among colorectal cancer patients presenting to a Tertiary Care Cancer Hospital. International Journal of Advanced Medical and Health Research 2022; 9(2): 107 doi: 10.4103/ijamr.ijamr_243_20
|
| 50 |
Bruno Märkl. Stage migration <italic>vs</italic> immunology: The lymph node count story in colon cancer. World Journal of Gastroenterology 2015; 21(43): 12218-12233 doi: 10.3748/wjg.v21.i43.12218
|
| 51 |
David Barras, Edoardo Missiaglia, Pratyaksha Wirapati, Oliver M. Sieber, Robert N. Jorissen, Chris Love, Peter L. Molloy, Ian T. Jones, Stephen McLaughlin, Peter Gibbs, Justin Guinney, Iris M. Simon, Arnaud D. Roth, Fred T. Bosman, Sabine Tejpar, Mauro Delorenzi.
BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression. Clinical Cancer Research 2017; 23(1): 104 doi: 10.1158/1078-0432.CCR-16-0140
|
| 52 |
Sofía del Carmen, Luís Antonio Corchete, Ruth Gervas, Alba Rodriguez, María Garcia, José Antonio Álcazar, Jacinto García, Oscar Bengoechea, Luis Muñoz-Bellvis, José María Sayagués, Mar Abad. Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61688-7
|
| 53 |
Mohammad Azhar Aziz, Zeyad Yousef, Ayman M. Saleh, Sameer Mohammad, Bandar Al Knawy. Towards personalized medicine of colorectal cancer. Critical Reviews in Oncology/Hematology 2017; 118: 70 doi: 10.1016/j.critrevonc.2017.08.007
|
| 54 |
Francesco Iachetta, Federica Domati, Luca Reggiani-Bonetti, Valeria Barresi, Giulia Magnani, Luigi Marcheselli, Claudia Cirilli, Monica Pedroni. Prognostic relevance of microsatellite instability in pT3N0M0 colon cancer: a population-based study. Internal and Emergency Medicine 2016; 11(1): 41 doi: 10.1007/s11739-015-1285-6
|
| 55 |
Andreas M. Kaiser. Chassin's Operative Strategy in General Surgery. 2022; : 395 doi: 10.1007/978-3-030-81415-1_53
|
| 56 |
Tao Chen, Yunqian Chu, Haiyuan Xu, Hanjue Dai, Yuxi Zhou, Haiwei Du, Wenyu Zhu. Kinesin superfamily member KIFC2 as an independent prognostic biomarker of colon adenocarcinoma associated with poor immune response. Medicine 2023; 102(43): e35491 doi: 10.1097/MD.0000000000035491
|
| 57 |
Mohammad Alzeyadi, Haneen Rabeea. Microsatellite instability detectable for Lung cancer Prognosis. Journal of Physics: Conference Series 2019; 1234(1): 012079 doi: 10.1088/1742-6596/1234/1/012079
|
| 58 |
João Cortez Pinto, Isadora Rosa, Catarina Martins, Inês Marques, João Pereira da Silva, Ricardo Fonseca, João Freire, António Dias Pereira. Colon Adenocarcinoma Stage IIA—Can We Predict Relapse?. Journal of Gastrointestinal Cancer 2020; 51(1): 116 doi: 10.1007/s12029-019-00218-9
|
| 59 |
Jesse Fischer, Logan C. Walker, Bridget A. Robinson, Frank A. Frizelle, James M. Church, Tim W. Eglinton. Clinical implications of the genetics of sporadic colorectal cancer. ANZ Journal of Surgery 2019; 89(10): 1224 doi: 10.1111/ans.15074
|
| 60 |
James H Park, Arfon G Powell, Campbell S D Roxburgh, Paul G Horgan, Donald C McMillan, Joanne Edwards. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment. British Journal of Cancer 2016; 114(5): 562 doi: 10.1038/bjc.2016.17
|
| 61 |
Hossein Taghizadeh, Robert M. Mader, Leonhard Müllauer, Friedrich Erhart, Alexandra Kautzky-Willer, Gerald W. Prager. Precision Medicine for the Management of Therapy Refractory Colorectal Cancer. Journal of Personalized Medicine 2020; 10(4): 272 doi: 10.3390/jpm10040272
|
| 62 |
Bo Young Oh, So-Young Kim, Yeo Song Lee, Hye Kyung Hong, Tae Won Kim, Seok Hyung Kim, Woo Yong Lee, Yong Beom Cho. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells. Oncotarget 2016; 7(35): 57066 doi: 10.18632/oncotarget.10974
|